Abstract
Background/Objectives:
The misincorporation of uracil into DNA leads to genomic instability. In a previous study, some of us identified four common single nucleotide polymorphisms (SNPs) in uracil-processing genes (rs2029166 and rs7296239 in SMUG1, rs34259 in UNG and rs4775748 in DUT) that were associated with significantly altered levels of uracil in human DNA. We investigated whether any of these SNPs are associated with an altered risk of developing breast cancer and if one-carbon nutrients intake can modify their effects.
Subjects/Methods:
We genotyped the four SNPs in 1077 cases of incident breast cancer and 1910 age and race-matched controls in the Western New York Exposures and Breast Cancer (WEB) Study and examined associations with breast cancer risk and interactions with intake of folate, vitamins B6 and B12.
Results:
After adjustment for known risk factors for breast cancer, there was increased risk of breast cancer among postmenopausal women who were heterozygous for either of the two SMUG1 SNPs (odds ratio (OR) 1.29, 95% confidence interval (CI) 1.07–1.56) and OR 1.29, 95% CI 1.07–1.55, respectively). Among premenopausal women, increased risk associated with the SMUG1 rs2029166 genotype was limited to those with low folate intake. There were no other interactions with vitamins B6 or B12 intake.
Conclusions:
Our study suggests that the four selected SNPs are not robust determinants of breast cancer risk, but that the two SNPs in SMUG1 might modestly alter the risk of breast cancer. However, the increase in risk among heterozygotes in the two SNPs in SMUG1, which is thought to be the most active glycosylase in vivo, raises the possibility that subtle ‘heterosis’ effects on cancer risk might be produced by these SNPs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ames BN (1999). Micronutrient deficiencies. A major cause of DNA damage. Ann N Y Acad Sci 889, 87–106.
Ames BN, Wakimoto P (2002). Are vitamin and mineral deficiencies a major cancer risk? Nat Rev Cancer 2, 694–704.
Barnes DE, Lindahl T (2004). Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet 38, 445–476.
Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L (1986). A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124, 453–469.
Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G et al. (1997). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94, 3290–3295.
Bonner MR, Han D, Nie J, Rogerson P, Vena JE, Muti P et al. (2005). Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev 14, 53–60.
Broderick P, Bagratuni T, Vijayakrishnan J, Lubbe S, Chandler I, Houlston RS (2006). Evaluation of NTHL1, NEIL1, NEIL2, MPG, TDG, UNG and SMUG1 genes in familial colorectal cancer predisposition. BMC Cancer 6, 243.
Chanson A, Parnell LD, Ciappio ED, Liu Z, Crott JW, Tucker KL et al. (2009). Polymorphisms in uracil-processing genes, but not one-carbon nutrients, are associated with altered DNA uracil concentrations in an urban Puerto Rican population. Am J Clin Nutr 89, 1927–1936.
Choi SW, Mason JB (2000). Folate and carcinogenesis: an integrated scheme. J Nutr 130, 129–132.
Comings DE, MacMurray JP (2000). Molecular heterosis: a review. Mol Genet Metab 71, 19–31.
Crow JF (2008). Mid-century controversies in population genetics. Annu Rev Genet 42, 1–16.
Fenech M (2001). The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat Res 475, 57–67.
Giovannucci E (2002). Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132, 2350S–2355S.
Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou G et al. (2004). Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 64, 4378–4384.
Hung RJ, Hall J, Brennan P, Boffetta P (2005). Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162, 925–942.
Jang H, Mason JB, Choi SW (2005). Genetic and epigenetic interactions between folate and aging in carcinogenesis. J Nutr 135, 2967S–2971S.
Kapiszewska M, Kalemba M, Wojciech U, Milewicz T (2005). Uracil misincorporation into DNA of leukocytes of young women with positive folate balance depends on plasma vitamin B12 concentrations and methylenetetrahydrofolate reductase polymorphisms. A pilot study. J Nutr Biochem 16, 467–478.
Kavli B, Otterlei M, Slupphaug G, Krokan HE (2007). Uracil in DNA—general mutagen, but normal intermediate in acquired immunity. DNA Repair (Amst) 6, 505–516.
Krokan HE, Drablos F, Slupphaug G (2002). Uracil in DNA—occurrence, consequences and repair. Oncogene 21, 8935–8948.
Mashiyama ST, Hansen CM, Roitman E, Sarmiento S, Leklem JE, Shultz TD et al. (2008). An assay for uracil in human DNA at baseline: effect of marginal vitamin B6 deficiency. Anal Biochem 372, 21–31.
Miao R, Gu H, Liu H, Hu Z, Jin G, Wang H et al. (2008). Tagging single nucleotide polymorphisms in MBD4 are associated with risk of lung cancer in a Chinese population. Lung Cancer 62, 281–286.
Mohrenweiser HW, Jones IM (1998). Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat Res 400, 15–24.
Salanti G, Southam L, Altshuler D, Ardlie K, Barroso I, Boehnke M et al. (2009). Underlying genetic models of inheritance in established type 2 diabetes associations. Am J Epidemiol 170, 537–545.
Shin MC, Lee SJ, Choi JE, Cha SI, Kim CH, Lee WK et al. (2006). Glu346Lys polymorphism in the methyl-CpG binding domain 4 gene and the risk of primary lung cancer. Jpn J Clin Oncol 36, 483–488.
Sousa MM, Krokan HE, Slupphaug G (2007). DNA-uracil and human pathology. Mol Aspects Med 28, 276–306.
Tao MH, Shields PG, Nie J, Millen A, Ambrosone CB, Edge SB et al. (2009). DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat 114, 559–568.
Tennis M, Krishnan S, Bonner M, Ambrosone CB, Vena JE, Moysich K et al. (2006). p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiol Biomarkers Prev 15, 80–85.
Visnes T, Doseth B, Pettersen HS, Hagen L, Sousa MM, Akbari M et al. (2009). Uracil in DNA and its processing by different DNA glycosylases. Philos Trans R Soc Lond B Biol Sci 364, 563–568.
Willett WC, Howe GR, Kushi LH (1997). Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65, 1220S–1228S.
Xu X, Chen J (2009). One-carbon metabolism and breast cancer: an epidemiological perspective. J Genet Genomics 36, 203–214.
Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD et al. (2003). Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 95, 373–380.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Marian, C., Tao, M., Mason, J. et al. Single nucleotide polymorphisms in uracil-processing genes, intake of one-carbon nutrients and breast cancer risk. Eur J Clin Nutr 65, 683–689 (2011). https://doi.org/10.1038/ejcn.2011.29
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2011.29
Keywords
This article is cited by
-
Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis
British Journal of Cancer (2014)
-
Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy
Breast Cancer Research and Treatment (2013)